OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 82 citing articles:

Mesoporous Silica Nanoparticles as a Potential Nanoplatform: Therapeutic Applications and Considerations
Krismala Djayanti, Pooja Maharjan, Kwan Hyung Cho, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6349-6349
Open Access | Times Cited: 54

Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics
Yashaswi Dutta Gupta, Yuri Mackeyev, Sunil Krishnan, et al.
Cancer Nanotechnology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 22

Recent advances in self-targeting natural product-based nanomedicines
Haifan Liu, Xingyue Jin, Suyi Liu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 7

Key Parameters for the Rational Design, Synthesis, and Functionalization of Biocompatible Mesoporous Silica Nanoparticles
Marta Florensa, Marina Llenas, Esperanza Medina-Gutiérrez, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2703-2703
Open Access | Times Cited: 41

Madecassoside mitigates acute myocardial infarction injury by activating the PKCB/SPARC signaling pathway
Peng Wang, Jing Yang, Dandan Xu, et al.
Acta Pharmacologica Sinica (2025)
Closed Access | Times Cited: 1

Pharmacokinetics and Biological Activities of Notoginsenoside R1: A Systematical Review
Chao Wen, Xiaofei Liao, Xinyun Ye, et al.
The American Journal of Chinese Medicine (2025), pp. 1-45
Closed Access | Times Cited: 1

Hydroxy-α-sanshool-loaded adipose-targeted mesoporous silica nanoparticles induce white adipose browning and reduce obesity by activating TRPV1
Qing Zhang, Cheng-Xun He, Juan Guo, et al.
Bio-Design and Manufacturing (2025)
Closed Access | Times Cited: 1

Use of Silica Nanoparticles for Drug Delivery in Cardiovascular Disease
Haritha Kirla, David J. Henry, Shirley Jansen, et al.
Clinical Therapeutics (2023) Vol. 45, Iss. 11, pp. 1060-1068
Closed Access | Times Cited: 21

Targeting the JAK2/STAT3 signaling pathway with natural plants and phytochemical ingredients: A novel therapeutic method for combatting cardiovascular diseases
Binyong Guo, Yunfeng Yu, Min Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116313-116313
Open Access | Times Cited: 7

Reprogramming monocytes into M2 macrophages as living drug depots to enhance treatment of myocardial ischemia-reperfusion injury
Yan Liu, Meiling Zhou, Maochang Xu, et al.
Journal of Controlled Release (2024) Vol. 374, pp. 639-652
Closed Access | Times Cited: 7

Targeting the PANoptosis signaling pathway for myocardial protection: therapeutic potential of Xian Ling Gu Bao capsule
Xiaoyu Wu, Jiajia Wei, Wenfang Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5

Advances in Nanoparticles in the Prevention and Treatment of Myocardial Infarction
Qidong Wei, Yifei Xiao, Lixin Du, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2415-2415
Open Access | Times Cited: 5

Notoginsenoside R1 attenuates ischemic heart failure by modulating MDM2/β arrestin2-mediated β2-adrenergic receptor ubiquitination
Qi Chen, Ziwei Huang, Jing Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117004-117004
Open Access | Times Cited: 5

Engineered nanovesicles mediated cardiomyocyte survival and neovascularization for the therapy of myocardial infarction
Juan Zhang, Beibei Zhang, Linlin Zhang, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 243, pp. 114135-114135
Closed Access | Times Cited: 5

Biomimetic nanoplatform treats myocardial ischemia/reperfusion injury by synergistically promoting angiogenesis and inhibiting inflammation
Fenting Lei, Jie Zhang, Yiping Deng, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 243, pp. 114159-114159
Closed Access | Times Cited: 5

Synergistic Effect of Magneto-Mechanical Bioengineered Stem Cells and Magnetic Field to Alleviate Osteoporosis
Congcong Yu, Wentao Yang, Linjun Yang, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 16, pp. 19976-19988
Closed Access | Times Cited: 13

Potential Immunoregulatory Mechanism of Plant Saponins: A Review
Liuhong Shen, Hao Luo, Lei Fan, et al.
Molecules (2023) Vol. 29, Iss. 1, pp. 113-113
Open Access | Times Cited: 11

Notoginsenoside R1 improves intestinal microvascular functioning in sepsis by targeting Drp1-mediated mitochondrial quality imbalance
Dongyao Hou, Ruixue Liu, Shuai Hao, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 250-260
Open Access | Times Cited: 4

Biodegradable copper-containing mesoporous microspheres loaded with ginsenoside Rb1 for infarcted heart repair
Dongmin Chen, X. D. Sheng, Huili Li, et al.
Biomaterials Advances (2025) Vol. 169, pp. 214172-214172
Closed Access

Fraxetin attenuates DNA damage and inflammation in cisplatin-induced nephrotoxicity via FoxO1 activation
Ziwei Yuan, Seung-Yoon Yu, Dongyan Su, et al.
International Immunopharmacology (2025) Vol. 147, pp. 114010-114010
Closed Access

Notoginsenoside R1 Attenuates H/R Injury in H9c2 Cells by Maintaining Mitochondrial Homeostasis
Yuanbo Xu, Piao Wang, Ting Hu, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 1, pp. 44-44
Open Access

Page 1 - Next Page

Scroll to top